Fatty liver and cirrhosis are not the same condition. Fatty liver is the earliest stage of liver disease, where excess fat builds up in liver cells. Cirrhosis is the most advanced stage, where years of damage have replaced healthy tissue with permanent scar tissue. Think of them as opposite ends of a spectrum: fatty liver is the beginning, cirrhosis is the end point, and several stages of worsening damage sit between them.
How Liver Disease Progresses in Stages
Liver disease doesn’t jump from fat buildup to cirrhosis overnight. It moves through a rough sequence of stages, and each one involves more damage than the last.
In the first stage, fat accumulates inside liver cells. This is simple fatty liver, and for many people it stays here indefinitely without causing problems. If the fat triggers ongoing inflammation, the disease enters a more active phase called steatohepatitis. Persistent inflammation then starts producing scar tissue, a process called fibrosis. Fibrosis is graded on a scale from F0 (no scarring) to F4. Once scarring becomes so widespread that it distorts the liver’s internal structure and blocks normal blood flow, the liver has reached cirrhosis (F4). If cirrhosis worsens further, the liver begins to fail.
Not everyone moves through every stage. Most people with simple fatty liver never develop significant scarring. A longitudinal study with over 15 years of follow-up found that only 1% of patients with simple fatty liver developed cirrhosis, compared with 11% of those who had the inflammatory form (steatohepatitis). The inflammatory form also progressed roughly twice as fast, advancing through fibrosis stages at double the rate.
What Each Condition Feels Like
One of the trickiest aspects of fatty liver is that it typically causes no symptoms at all. When it does, the signs are vague: fatigue and a general sense of not feeling well. Most people discover they have fatty liver incidentally, through blood work or imaging done for another reason.
Cirrhosis, especially in its later stages, is a different experience entirely. As scar tissue blocks blood flow through the liver, pressure builds in the veins feeding into it. That pressure triggers a cascade of problems: fluid accumulates in the abdomen (ascites), swollen veins in the esophagus or stomach can rupture and bleed, and toxins the liver normally filters start affecting brain function, causing confusion and disorientation. Bleeding from ruptured veins carries a 10% to 20% mortality rate within six weeks. Kidney function can also deteriorate as the body’s circulatory system becomes increasingly strained. None of these complications occur with simple fatty liver.
The Reversibility Question
This is where the distinction between fatty liver and cirrhosis matters most. Simple fatty liver is entirely reversible. Losing weight, improving diet, managing blood sugar, and reducing alcohol intake can clear fat from the liver completely. Even mild to moderate scarring (fibrosis) can reverse with effective treatment of the underlying cause. Repeat biopsies in patients successfully treated for liver disease have shown previously scarred tissue returning to normal.
Cirrhosis, however, is generally considered irreversible. As scar tissue matures, the collagen fibers within it form chemical bonds called crosslinks. These crosslinks are so stable that the body’s own enzymes cannot break them down. The point of no return appears to be when this extensive crosslinking has occurred. Some early cirrhosis may partially improve with aggressive treatment, but advanced cirrhosis with complications does not reverse. This is why catching liver disease before it reaches cirrhosis changes the entire outlook.
What Pushes Fatty Liver Toward Cirrhosis
Several factors determine whether fatty liver stays harmless or progresses. The single biggest predictor is whether inflammation develops. Once the liver is actively inflamed (steatohepatitis rather than simple fat storage), the clock starts ticking faster. Among patients with steatohepatitis who already have advanced scarring (F3), about 22% progress to cirrhosis within just two years. A separate analysis found that roughly 21% of patients are “rapid progressors” who develop advanced scarring from minimal or no fibrosis over an average of about six years.
Diabetes is the strongest metabolic driver. A large Canadian study matching over 400,000 people with newly diagnosed diabetes to more than 2 million without it found that people with diabetes developed cirrhosis at nearly three times the rate (3.7% versus 1.3%) over about six years. High blood sugar appears to promote cirrhosis independently of obesity. Other metabolic risk factors, including high cholesterol, obesity, and high blood pressure, also accelerate progression.
Genetics play a meaningful role too. Inherited factors are estimated to account for 30% to 50% of the risk for conditions like obesity, diabetes, and cirrhosis. Researchers have identified specific gene variants that increase susceptibility to liver scarring, and these variants have been confirmed across multiple patient groups with biopsy-proven disease.
Updated Medical Terminology
If you’ve seen different names used for fatty liver disease, you’re not confused. The medical community recently overhauled its terminology. What was called nonalcoholic fatty liver disease (NAFLD) is now metabolic dysfunction-associated steatotic liver disease (MASLD). The inflammatory form, previously NASH, is now called MASH. These new names reflect the understanding that metabolic problems like high blood sugar and obesity drive the disease, rather than simply defining it by the absence of alcohol use. MASLD affects more than 30% of the global population.
A new category called MetALD also now exists for people who have metabolic fatty liver disease and drink moderate to heavy amounts of alcohol. One important diagnostic detail: even when fat disappears from a cirrhotic liver (which can happen as the disease burns through liver cells), the diagnosis of fatty liver-related cirrhosis still stands if the original cause was metabolic. Cirrhosis doesn’t stop being cirrhosis just because the fat is gone.
How Doctors Tell Them Apart
Distinguishing fatty liver from cirrhosis usually starts with a specialized ultrasound called FibroScan, which measures two things simultaneously. It gauges how much fat is in the liver using a reading measured in decibels per meter (ranging from 100 to 400), and it measures liver stiffness in kilopascals (ranging from 1.5 to 75). A soft liver with high fat content points to simple fatty liver. A stiff liver indicates scarring, and increasingly high stiffness values correspond to more advanced fibrosis and eventually cirrhosis. Blood tests that calculate fibrosis scores, imaging like MRI, and sometimes liver biopsy round out the picture when the initial results are unclear.